DDW 2022, News
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
While food allergies may affect response to the medication, environmental allergies do not, the report says.
Drugs in the Pipeline
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
Increased incidence of CAP was noted in stroke patients using PPIs.
Study is the largest to explore this potential safety issue to date.
Bylvay is an oral reversible inhibitor of the ileal bile acid transporter.